E-LIB Suche - Ergebnisse für: Thom, H

1

Long-term cost-effectiveness of case-finding and mass-scree..:

Heijdra Suasnabar, J.M. ; Meijer, C.R. ; Smit, L....
Gastroenterology. , 2024

Link: https://doi.org/10.1053/..

2

MSR79 Matching Plus Regression Adjustment for the Estimatio..:

Di Maio, D. ; Mitchell, S. ; Batson, S...
Value in Health. 26 (2023) 12 - p. S408 , 2023

Link: https://doi.org/10.1016/..

3

CO88 A Matching-Adjusted Indirect Comparison of the Efficac..:

Maksymowych, W.P. ; Thom, H. ; Mørup, M....
Value in Health. 26 (2023) 12 - p. S30 , 2023

Link: https://doi.org/10.1016/..

4

CO49 A Matching-Adjusted Indirect Comparison of the Efficac..:

Thom, H. ; Gaffney, K. ; Mørup, M....
Value in Health. 26 (2023) 12 - p. S22-S23 , 2023

Link: https://doi.org/10.1016/..

5

EE136 Cost-Effectiveness Analysis for Implants of Knee Repl..:

Xu, Y. ; Thom, H. ; Hunt, L.P....
Value in Health. 26 (2023) 6 - p. S84 , 2023

Link: https://doi.org/10.1016/..

6

EE192 The Cost-Effectiveness of a Bimekizumab Versus Secuki..:

Mørup, M.F. ; Taieb, V. ; Willems, D....
Value in Health. 26 (2023) 12 - p. S88 , 2023

Link: https://doi.org/10.1016/..

7

SA41 Novel Method for Indirect Comparison of Treatment Sequ..:

Aceituno, D. ; Grossman, J. ; Paracha, N...
Value in Health. 26 (2023) 12 - p. S549 , 2023

Link: https://doi.org/10.1016/..

8

POSA39 Cost-Effectiveness Analysis of Nivolumab for the Adj..:

Amadi, A ; Toor, K ; Keeney, E...
Value in Health. 25 (2022) 1 - p. S40 , 2022

Link: https://doi.org/10.1016/..

9

CO78 Matching-Adjusted Indirect Comparison of Futibatinib V..:

Paine, A ; Thom, H ; Wacheck, V...
Value in Health. 25 (2022) 12 - p. S33 , 2022

Link: https://doi.org/10.1016/..

10

Cluster randomised controlled trial of screening for atrial..:

Williams, Kate ; Modi, Rakesh Narendra ; Dymond, Andrew...
BMJ Open. 12 (2022) 9 - p. e065066 , 2022

Link: https://doi.org/10.1136/..

11

POSB38 Developing a Cost-Effectiveness Analysis for Nivolum..:

Amadi, A ; Toor, K ; Keeney, E...
Value in Health. 25 (2022) 1 - p. S67 , 2022

Link: https://doi.org/10.1016/..

12

PSU4 VALUE of Information for Adaptive Trials: Proof of Con..:

Ward, M. ; Grayling, M. ; Wason, J....
Value in Health. 23 (2020) - p. S738 , 2020

Link: https://doi.org/10.1016/..

13

PMD18 - IMPACT OF DIFFERENT IOL MATERIALS ON THE INCIDENCE ..:

Thom, H. ; Ender, F. ; Perez Vives, C....
Value in Health. 21 (2018) - p. S245 , 2018

Link: https://doi.org/10.1016/..

14

Secukinumab Shows Higher Symptomatic improvement Versus Inf..:

Strand, V ; McInnes, I ; Thom, H...
Value in Health. 20 (2017) 9 - p. A935-A936 , 2017

Link: https://doi.org/10.1016/..

15

Comparative Effectiveness of Secukinumab and Adalimumab in ..:

Maksymowych, WP ; Walsh, J ; Thom, H...
Value in Health. 20 (2017) 9 - p. A935 , 2017

Link: https://doi.org/10.1016/..